Pay in 4 interest-free payments of $12.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
(2012) Cancer Res
InChiKey: ZCDBTQNFAPKACC-UHFFFAOYSA-N
Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors
24(2):167-176
InChiKey: OJXYMYYDAVXPIK-IWKNALKQSA-N
JNK-IN-8 - CAS# 1410880-22-6 60136 (2012) Cancer ResJNK IN 8, also known as JNK Inhibitor XVI, CAS No. 1410880 22 6, is a selective JNK inhibitor that inhibits phosphorylation of c Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue. Extensive biochemical, cellular, and pathway based profiling establish the selectivity of JNK IN 8 for JNK and suggests that the compound will be broadly useful as a
US$ 85.00
US$ 38.00
US$ 1309000.00
US$ 1095000.00
US$ 721500.00
US$ 908000.00
US$ 96.00
US$ 125.00
US$ 910000.00
US$ 1042000.00
US$ 828000.00
US$ 481000.00
US$ 85.00